Eric Drape Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

Eric Drape is Executive VP Global Operations of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 145,915 shares of TEVA, which is worth approximately $2.5 Million. The most recent transaction as insider was on Mar 05, 2024, when has been sold 77,802 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K

0% 3M change

15.78% 12M change

Total Value Held $2.5 Million

Eric Drape Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	BUY Exercise of conversion of derivative security	-	77,802 Added 34.78%	145,915 Ordinary Shares
Mar 04 2024	BUY Exercise of conversion of derivative security	-	33,512 Added 30.07%	77,928 Ordinary Shares
Mar 03 2024	BUY Exercise of conversion of derivative security	-	24,900 Added 35.92%	44,416 Ordinary Shares
Feb 28 2024	SELL Open market or private sale	$128,772 $13.12 p/Share	9,815 Reduced 50.29%	9,701 Ordinary Shares
Feb 28 2024	BUY Exercise of conversion of derivative security	-	19,515 Added 50.0%	19,516 Ordinary Shares
Feb 16 2024	SELL Open market or private sale	$2,261,056 $13.05 p/Share	173,261 Reduced 100.0%	1 Ordinary Shares
Mar 07 2023	SELL Open market or private sale	$44,311 $9.43 p/Share	4,699 Reduced 2.64%	173,262 Ordinary Shares
Mar 06 2023	SELL Open market or private sale	$15,550 $9.93 p/Share	1,566 Reduced 0.87%	177,961 Ordinary Shares
Mar 05 2023	BUY Exercise of conversion of derivative security	-	22,576 Added 11.17%	179,527 Ordinary Shares
Mar 04 2023	BUY Exercise of conversion of derivative security	-	45,452 Added 22.46%	156,951 Ordinary Shares
Feb 28 2023	SELL Open market or private sale	$333,144 $9.89 p/Share	33,685 Reduced 23.2%	111,499 Ordinary Shares
Feb 28 2023	BUY Exercise of conversion of derivative security	-	67,112 Added 33.14%	135,387 Ordinary Shares
Mar 07 2022	SELL Open market or private sale	$83,532 $7.37 p/Share	11,334 Reduced 12.68%	78,072 Ordinary Shares
Mar 05 2022	BUY Exercise of conversion of derivative security	-	22,576 Added 20.16%	89,406 Ordinary Shares
Mar 04 2022	SELL Open market or private sale	$175,466 $7.48 p/Share	23,458 Reduced 25.98%	66,830 Ordinary Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	-	44,458 Added 37.81%	73,131 Ordinary Shares
Feb 28 2022	SELL Open market or private sale	$79,748 $8.14 p/Share	9,797 Reduced 17.61%	45,830 Ordinary Shares
Feb 28 2022	BUY Exercise of conversion of derivative security	-	19,514 Added 25.97%	55,627 Ordinary Shares
Feb 09 2022	SELL Open market or private sale	$32,462 $9.06 p/Share	3,583 Reduced 9.03%	36,113 Ordinary Shares
Feb 09 2022	BUY Exercise of conversion of derivative security	-	6,568 Added 14.2%	39,696 Ordinary Shares
May 21 2021	SELL Open market or private sale	$440,400 $11.01 p/Share	40,000 Reduced 54.7%	33,128 Ordinary Shares
May 11 2021	SELL Open market or private sale	$202,397 $10.22 p/Share	19,804 Reduced 21.31%	73,128 Ordinary Shares
May 11 2021	BUY Exercise of conversion of derivative security	-	37,884 Added 28.96%	92,932 Ordinary Shares
Mar 04 2021	SELL Open market or private sale	$65,416 $10.58 p/Share	6,183 Reduced 10.1%	55,048 Ordinary Shares
Mar 04 2021	BUY Exercise of conversion of derivative security	-	11,940 Added 16.32%	61,231 Ordinary Shares

Eric Drape

Executive VP Global Operations

Tel Aviv, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Value

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA

Account